Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
52.43
Dollar change
-1.04
Percentage change
-1.95
%
IndexRUT P/E- EPS (ttm)-9.16 Insider Own12.91% Shs Outstand94.54M Perf Week4.78%
Market Cap5.29B Forward P/E- EPS next Y-6.33 Insider Trans1.37% Shs Float82.34M Perf Month-2.42%
Income-746.61M PEG- EPS next Q-1.70 Inst Own89.53% Short Float11.33% Perf Quarter33.38%
Sales0.00M P/S- EPS this Y-52.93% Inst Trans12.70% Short Ratio9.67 Perf Half Y55.21%
Book/sh4.16 P/B12.62 EPS next Y27.72% ROA-137.07% Short Interest9.33M Perf Year89.83%
Cash/sh4.33 P/C12.11 EPS next 5Y- ROE-193.67% 52W Range26.80 - 62.21 Perf YTD22.50%
Dividend Est.- P/FCF- EPS past 5Y- ROI-182.13% 52W High-15.72% Beta3.98
Dividend TTM- Quick Ratio3.27 Sales past 5Y0.00% Gross Margin- 52W Low95.63% ATR (14)2.30
Dividend Ex-Date- Current Ratio3.27 EPS Y/Y TTM-44.95% Oper. Margin0.00% RSI (14)55.97 Volatility3.93% 4.18%
Employees239 Debt/Eq0.08 Sales Y/Y TTM- Profit Margin- Recom1.13 Target Price64.31
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-175.22% Payout- Rel Volume0.63 Prev Close53.47
Sales Surprise- EPS Surprise-104.41% Sales Q/Q- EarningsAug 08 AMC Avg Volume964.86K Price52.43
SMA201.15% SMA5010.83% SMA20020.00% Trades Volume611,969 Change-1.95%
Date Action Analyst Rating Change Price Target Change
Sep-16-24Initiated Jefferies Buy $57
Sep-04-24Initiated Bernstein Outperform $55
Jul-24-24Initiated Morgan Stanley Overweight $58
Feb-16-24Initiated RBC Capital Mkts Outperform $62
Feb-06-24Initiated UBS Buy $59
Dec-22-23Initiated H.C. Wainwright Buy $50
Dec-08-23Initiated Robert W. Baird Outperform $58
Jan-24-23Initiated SVB Securities Outperform $24
Jan-04-23Initiated JP Morgan Overweight $23
Dec-02-22Initiated BTIG Research Buy $24
Oct-07-24 04:13PM
09:41AM
Oct-02-24 04:05PM
Oct-01-24 06:00AM
Sep-30-24 04:05PM
07:30AM Loading…
07:30AM
Sep-23-24 07:30AM
Sep-20-24 07:09PM
Aug-08-24 08:21PM
04:05PM
Jul-01-24 07:00AM
Jun-28-24 10:00AM
May-29-24 07:30AM
07:15AM
May-15-24 11:00AM
09:35AM Loading…
May-14-24 09:35AM
May-13-24 09:35AM
May-09-24 11:54PM
04:05PM
May-01-24 02:38PM
Apr-26-24 06:00AM
Apr-25-24 11:00AM
Apr-23-24 11:00AM
Apr-22-24 04:05PM
Apr-18-24 06:00AM
Apr-17-24 04:05PM
Apr-13-24 09:00AM
Apr-03-24 10:03PM
Feb-29-24 04:05PM
Jan-25-24 05:31PM
07:00AM Loading…
Jan-22-24 07:00AM
Jan-08-24 07:30AM
Jan-02-24 07:00AM
Dec-31-23 03:01AM
Dec-01-23 04:30PM
Nov-16-23 09:40AM
Nov-14-23 09:15PM
04:05PM
Nov-06-23 08:50AM
Oct-31-23 09:40AM
Oct-19-23 08:50AM
Oct-16-23 07:00AM
Oct-06-23 01:01PM
Oct-05-23 04:05PM
Oct-03-23 08:50AM
Oct-02-23 11:56PM
04:36PM
Sep-29-23 10:00AM
10:00AM
Sep-28-23 07:53AM
Sep-27-23 04:09PM
12:25PM
12:00PM
Sep-14-23 07:00AM
Sep-05-23 07:00AM
Aug-09-23 06:01AM
Jul-31-23 09:31AM
06:59AM
Jul-27-23 12:50PM
07:00AM
Jun-27-23 05:31AM
Jun-02-23 09:11AM
Jun-01-23 04:08PM
01:01PM
11:29AM
May-31-23 07:00AM
May-25-23 05:00PM
May-24-23 01:30PM
May-12-23 04:30PM
May-05-23 10:43AM
Apr-17-23 07:00AM
Mar-30-23 09:40AM
Mar-25-23 09:22AM
Mar-23-23 04:05PM
11:09AM
Mar-22-23 07:30AM
Mar-14-23 07:30AM
Mar-13-23 11:39AM
Feb-23-23 08:36AM
Feb-21-23 07:30AM
Feb-10-23 02:55PM
Feb-02-23 12:52PM
Jan-06-23 07:58AM
07:30AM
Jan-05-23 09:40AM
Dec-23-22 06:21AM
Nov-29-22 09:35AM
Nov-28-22 09:55AM
Nov-21-22 09:33AM
Nov-09-22 08:35AM
07:00AM
Nov-08-22 11:52AM
Nov-06-22 11:48AM
07:00AM
Nov-01-22 10:01AM
Oct-25-22 08:21PM
04:30PM
Oct-20-22 10:30PM
Oct-18-22 04:12PM
Oct-07-22 03:24AM
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHILDS JOHN WDirectorOct 02 '24Buy47.5021,052999,97021,052Oct 03 07:01 AM
Coric VladChief Executive OfficerOct 02 '24Buy47.5021,052999,970861,942Oct 03 07:00 AM
Bailey GregoryDirectorSep 24 '24Buy44.195,000220,9661,620,071Sep 25 07:30 AM
CHILDS JOHN WDirectorJul 18 '24Buy35.6728,4001,012,9832,339,741Jul 19 08:56 AM
Car BruceChief Scientific OfficerJun 17 '24Buy33.5830,0001,007,49030,000Jun 20 07:30 AM
CHILDS JOHN WDirectorMay 30 '24Buy35.5828,000996,2402,311,341May 31 09:04 AM
Bailey GregoryDirectorMay 13 '24Buy34.1915,000512,8771,615,071May 15 07:31 AM
CHILDS JOHN WDirectorMay 13 '24Buy35.1728,5001,002,4702,283,341May 14 07:30 AM
Bailey GregoryDirectorApr 24 '24Buy39.1825,503999,1691,600,071Apr 25 07:32 AM
Bailey GregoryDirectorApr 22 '24Buy41.0048,7801,999,9801,574,568Apr 23 07:54 AM
CHILDS JOHN WDirectorApr 22 '24Buy41.00195,1217,999,9614,096,512Apr 23 07:54 AM
Coric VladChief Executive OfficerApr 22 '24Buy41.00121,9514,999,9911,788,417Apr 23 07:54 AM
Antonijevic IrinaDirectorDec 29 '23Option Exercise0.0011,000013,535Dec 29 06:25 PM
Antonijevic IrinaDirectorDec 29 '23Sale41.7911,000459,6622,535Dec 29 06:25 PM